Improving treatment outcomes for patients with aortic dissection
2/2 IMPRroving Outcomes in Vascular DisEase - Aortic Dissection (IMPROVE-AD)
This study is looking at two different ways to treat patients with uncomplicated type B aortic dissection to see which works better: one group will get medicine plus a quick surgery to fix the problem, while the other group will just get medicine and regular check-ups. They're hoping to include 1,100 people from across the U.S. to help find the best way to manage this condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10892225 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of two treatment strategies for patients with uncomplicated type B aortic dissection. One group will receive medical therapy combined with immediate thoracic endovascular aortic repair (TEVAR), while the other will receive medical therapy with ongoing monitoring for any deterioration. The study aims to enroll 1,100 participants across the United States and will provide valuable insights into the best management practices for this condition. The trial is led by a team of experienced researchers from prominent institutions, ensuring a robust approach to data collection and analysis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with uncomplicated type B aortic dissection who require treatment.
Not a fit: Patients with complicated type B aortic dissection or those who are not eligible for either treatment strategy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment protocols that enhance survival rates and quality of life for patients with aortic dissection.
How similar studies have performed: Previous research has indicated that similar approaches to managing aortic dissection have shown promise, but this trial is unique in its scale and design.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: O'brien, Sean M — Duke University
- Study coordinator: O'brien, Sean M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.